Gustafson Deborah
Institute of Neuroscience and Physiology, Sahlgrenska University Hospital, SE 413-45, Göteborg, Sweden.
Lancet Neurol. 2006 Aug;5(8):713-20. doi: 10.1016/S1474-4422(06)70526-9.
Indicators of adiposity, such as body-mass index (BMI), may be markers for changes in energy metabolism that influence dementia risk, progression, and ultimately death. Cross-sectional studies show that people with dementia have a lower BMI than those without dementia, which is potentially due to a greater rate of BMI decline occurring during the years immediately preceding dementia onset. However, a high BMI can also increase the risk for dementia when measured before clinical dementia onset, which might be due to vascular disorders or bioactive hormonal compounds that are secreted by adipose tissue. In this personal view, I consider how dementia is associated with BMI by looking at the role of BMI and obesity syndromes, mechanisms associated with adiposity, and the potential for hypothalamic dysregulation during the life course. Understanding the life course of adiposity by use of common surrogate measures, such as BMI, among those who do and do not develop dementia is relevant for understanding the causes of dementia and for shaping possible treatment options.
肥胖指标,如体重指数(BMI),可能是能量代谢变化的标志物,这些变化会影响痴呆症风险、进展以及最终的死亡。横断面研究表明,患有痴呆症的人的BMI低于未患痴呆症的人,这可能是由于在痴呆症发病前几年BMI下降速度更快。然而,在临床痴呆症发病前测量时,高BMI也会增加患痴呆症的风险,这可能是由于血管疾病或脂肪组织分泌的生物活性激素化合物所致。在这篇个人观点文章中,我通过审视BMI和肥胖综合征的作用、与肥胖相关的机制以及生命历程中下丘脑调节异常的可能性,来探讨痴呆症与BMI之间的关联。通过使用常见的替代指标,如BMI,来了解患痴呆症和未患痴呆症人群的肥胖生命历程,对于理解痴呆症的病因以及制定可能的治疗方案具有重要意义。